Vertex Pharmaceuticals: 2025 TIME100 Most Influential CompaniesBoston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR ...

Green hydrogen is fuelling the shift to sustainable energy. It offers a low-emission solution for energy storage and diverse transportation applications.

Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 staffers out of a job. | The company is merging its three buildings ...

See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

PROVIDENCE — As Vertex Pharmaceuticals Inc. looks to consolidate its properties around Rhode Island, executives told state officials they plan to slash dozens of jobs and shutter two offices.

In trading on Friday, shares of Vertex Inc (Symbol: VERX) entered into oversold territory, hitting an RSI reading of 27.8, after changing hands as low as $34.1938 per share.

About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions.

Vertex Pharmaceuticals is laying off workers and consolidating its real estate footprint in Rhode Island after ending a clinical program for Type 1 diabetes.

Vertex will host an investor event on Friday, June 20, 2025, at 7:15 p.m. CT/8:15 p.m. ET, in Chicago, to discuss the positive zimislecel data in type 1 diabetes.

Saudi Arabia’s NEOM Green Hydrogen Project is 80% complete, on track to start green ammonia exports by 2027.

The Senate is considering a plan to save a lucrative tax credit for the production of hydrogen that would be scrapped in the tax-and-spending mega bill passed by the House, key Republicans said.

Read about Vertex Pharmaceuticals Inc (VRTX:XNAS) stock and today's latest news and financial updates.